566 related articles for article (PubMed ID: 19506356)
21. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
[TBL] [Abstract][Full Text] [Related]
22. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Ginsburg D; Sadler JE
Thromb Haemost; 1993 Feb; 69(2):177-84. PubMed ID: 8456431
[TBL] [Abstract][Full Text] [Related]
23. Genetics of type 1 von Willebrand disease.
Goodeve A
Curr Opin Hematol; 2007 Sep; 14(5):444-9. PubMed ID: 17934350
[TBL] [Abstract][Full Text] [Related]
24. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
[TBL] [Abstract][Full Text] [Related]
25. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
Keeney S; Cumming A; Hay C
Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
[TBL] [Abstract][Full Text] [Related]
26. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
27. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
Penas N; Pérez-Rodríguez A; Torea JH; Lourés E; Noya MS; López-Fernández MF; Batlle J
Am J Hematol; 2005 Nov; 80(3):188-96. PubMed ID: 16247740
[TBL] [Abstract][Full Text] [Related]
28. Compound heterozygosity for two novel mutations (1203insG/Y1456X) in the von Willebrand factor gene causing type 3 von Willebrand disease.
Xie F; Wang X; Cooper DN; Lan F; Fang Y; Cai X; Wang Z; Wang H
Haemophilia; 2007 Sep; 13(5):645-8. PubMed ID: 17880457
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism and classification of von Willebrand disease.
Sadler JE; Matsushita T; Dong Z; Tuley EA; Westfield LA
Thromb Haemost; 1995 Jul; 74(1):161-6. PubMed ID: 8578450
[TBL] [Abstract][Full Text] [Related]
30. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
Nesbitt IM; Hampton KK; Preston FE; Peake IR; Goodeve AC
Thromb Haemost; 1999 Sep; 82(3):1061-4. PubMed ID: 10494764
[TBL] [Abstract][Full Text] [Related]
31. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
[TBL] [Abstract][Full Text] [Related]
32. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
[TBL] [Abstract][Full Text] [Related]
33. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
Wang Y; Zhang J; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):117-9. PubMed ID: 11601234
[TBL] [Abstract][Full Text] [Related]
34. Von Willebrand disease - phenotype versus genotype: deficiency versus disease.
Lillicrap D
Thromb Res; 2007; 120 Suppl 1():S11-6. PubMed ID: 17490730
[TBL] [Abstract][Full Text] [Related]
35. Understanding von Willebrand's disease from gene defects to the patients.
Zhang Z; Blombäck M; Anvret M
J Intern Med Suppl; 1997; 740():115-9. PubMed ID: 9350192
[TBL] [Abstract][Full Text] [Related]
36. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology.
Eikenboom JC
Best Pract Res Clin Haematol; 2001 Jun; 14(2):365-79. PubMed ID: 11686105
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
38. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
Hommais A; Stépanian A; Fressinaud E; Mazurier C; Pouymayou K; Meyer D; Girma JP; Ribba AS
Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067
[TBL] [Abstract][Full Text] [Related]
39. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
40. Type 1 von Willebrand disease: application of emerging data to clinical practice.
Collins PW; Cumming AM; Goodeve AC; Lillicrap D
Haemophilia; 2008 Jul; 14(4):685-96. PubMed ID: 18510569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
